Important drug-micronutrient interactions: A selection for clinical practice

被引:24
|
作者
Groeber, Uwe [1 ]
Schmidt, Joachim [1 ]
Kisters, Klaus [1 ,2 ]
机构
[1] Acad Micronutrient Med, Essen, Germany
[2] St Anna Hosp, Med Klin 1, Herne, Germany
关键词
Micronutrient; drug; interactions; proton pump inhibitors; vitamin B12; magnesium; Metformin; thiazide diuretics; statins; selenium; vitamin D; coenzyme Q10; PROTON-PUMP INHIBITOR; IRON-DEFICIENCY ANEMIA; STATIN-ASSOCIATED MYOPATHY; SERUM METHYLMALONIC ACID; RECEPTOR ANTAGONIST USE; VITAMIN-D DEFICIENCY; LONG-TERM TREATMENT; MUSCLE SYMPTOMS; COBALAMIN DEFICIENCY; HELICOBACTER-PYLORI;
D O I
10.1080/10408398.2018.1522613
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
Interactions between drugs and micronutrients have received only little or no attention in the medical and pharmaceutical world in the past. Since more and more pharmaceutics are used for the treatment of patients, this topic is increasingly relevant. As such interactions-depending on the duration of treatment and the status of micronutrients-impact the health of the patient and the action of the drugs, physicians and pharmacists should pay more attention to such interactions in the future. This review aims to sensitize physicians and pharmacists on drug micronutrient interactions with selected examples of widely pescribed drugs that can precipitate micronutrient deficiencies. In this context, the pharmacist, as a drug expert, assumes a particular role. Like no other professional in the health care sector, he is particularly predestined and called up to respond to this task. The following article intends to point out the relevance of mutual interactions between micronutrients and various examples of widely used drugs, without claiming to be exhaustive.
引用
收藏
页码:257 / 275
页数:19
相关论文
共 50 条
  • [1] Drug-micronutrient interactions: food for thought and thought for action
    Vasiliki Karadima
    Christina Kraniotou
    George Bellos
    George Th. Tsangaris
    EPMA Journal, 2016, 7
  • [2] Drug-micronutrient interactions: food for thought and thought for action
    Karadima, Vasiliki
    Kraniotou, Christina
    Bellos, George
    Tsangaris, George Th.
    EPMA JOURNAL, 2016, 7
  • [3] Drug-drug interactions in clinical practice
    Depont, Fanny
    Vargas, Frederic
    Dutronc, Herve
    Giauque, Emmanuelle
    Ragnaud, Jean-Marie
    Galperine, Tatiana
    Abouelfath, Abdelilah
    Valentino, Ruddy
    Dupon, Michel
    Hebert, Guillaume
    Moore, Nicholas
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2007, 16 (11) : 1227 - 1233
  • [4] Drug interactions with micronutrient metabolism
    Girard, Julie
    Galinier, Anne
    Caspar-Bauguil, Sylvie
    CAHIERS DE NUTRITION ET DE DIETETIQUE, 2022, 57 (05): : 305 - 314
  • [5] PHARMACOKINETIC DRUG INTERACTIONS IN CLINICAL PRACTICE
    OMALLEY, K
    IRISH MEDICAL JOURNAL, 1974, 67 (17) : 469 - 472
  • [6] Venlafaxine drug-drug interactions in clinical practice
    Benazzi, F
    JOURNAL OF PSYCHIATRY & NEUROSCIENCE, 1998, 23 (03): : 181 - 182
  • [7] THE CLINICAL CONSEQUENCES OF EXPOSURE TO CLINICALLY IMPORTANT DRUG-DRUG INTERACTIONS
    Malone, D. C.
    Hines, L. E.
    Brown, S.
    VALUE IN HEALTH, 2012, 15 (04) : A191 - A191
  • [8] ARE DRUG INTERACTIONS IMPORTANT
    BRECKENRIDGE, AM
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1976, 26 (06): : 1260 - 1261
  • [9] CLINICAL PHARMACOKINETICS AND POTENTIALLY IMPORTANT DRUG-INTERACTIONS OF SULPHINPYRAZONE
    PEDERSEN, AK
    JAKOBSEN, P
    KAMPMANN, JP
    HANSEN, JM
    CLINICAL PHARMACOKINETICS, 1982, 7 (01) : 42 - 56
  • [10] MICRONUTRIENT SUPPLEMENTS - TOXICITY AND DRUG-INTERACTIONS
    FLODIN, NW
    PROGRESS IN FOOD AND NUTRITION SCIENCE, 1990, 14 (04): : 277 - 331